The need for HIV vaccine awareness among Nigerians

The need for HIV vaccine awareness among Nigerians

By William Rashidi, 2018 AVAC Fellow

Within the last decade, persons living with HIV have witnessed improved drug regimen compared to the past when these persons take a cocktail of drugs to help the immune system respond to the virus. The continued advances in treatment are delightful and hold optimism, even as scientists double efforts to find a vaccine or cure.

But then some questions need to be asked; what is the level of awareness of persons living with HIV to the current efforts of finding either a preventive or a therapeutic vaccine? How informed is the Nigerian populace on HIV vaccine and preventive research? What is the Nigerian government investment in research for treatment and vaccine?

The need to be aware of current efforts in HIV vaccine and to direct our advocacy efforts towards ensuring sustainable funding for research to develop a safe and effective vaccine, is because we know a HIV vaccine will contribute to the control of the epidemic in the short run, and can lead to the eradication of HIV infection in the long run.

Nigeria has the second largest burden of HIV.  Its poor HIV management makes the leading source of new HIV infection in the world. Prevention of mother to child coverage is only at 31%. Nigeria needs to take up leadership and contribute significantly to HIV and AIDS research, including HIV vaccine research and development.

Nigeria can fund capacity development programs for its local researchers. It can also initiate and fund collaborative HIV vaccine research efforts with leading institutions around the world in ways that ensures Nigeria’s peculiarities are addressed in the global HIV vaccine research enterprise.

At this remarkable time in the history of HIV prevention science, we need to sustain our current efforts at developing a HIV vaccine. We need to support all promising interventions and move them to scale. We need to prepare regulatory pathways to ensure fast tracked access once developed.

We can and will keep hope alive, conquer our fear of HIV, eradicate stigma, remove structural barriers and inform ourselves of the giant efforts of researchers and scientist working towards a world that is free of HIV.

Leaving No One Behind:  The need for Nigeria to urgently prioritize investments in HIV biomedical research, HIV vaccine development

 

Equal Health and Rights Access Advocacy Initiative (EHRAAI)’s Press Statement to mark HIV Vaccine Awareness Day

HIV and AIDS is a public health issues in Nigeria. There is still no known vaccine that can be used to stem HIV infection. While we celebrate those working to develop a HIV Vaccine, we also choose to celebrate all those working assiduously for HIV Control.

On May 18, 1997, US President Bill Clinton committed to developing an AIDS vaccine within 10 years. 20 years later, we still don’t have one though we acknowledge the tremendous ongoing efforts in the field.

While we await the development of an HIV and or AIDS vaccine, we celebrate the successes with HIV control in Nigeria. PrEP access for serodiscordant couples through the NACA-led demonstration project and PrEP access to MSM through a demonstration project by PEPFAR in Nigeria needs to be celebrated.  However, new concerns of increasing HIV incidences pose a great threat to our current HIV response.

 HIV prevention and treatment services are expanding through the use of community based approaches. HIV treatment and prevention services are slowly being decentralized to primary health care centres and few community organisations . There are lots of ongoing initiatives to ensure that vulnerable and key populations have access to HIV treatment and prevention services. However, people who inject drugs seem to be left behind.

The current domestic funding of the National HIV response is a concern: only 27.07% of the country’s HIV response is funded by the National government. Nigeria is largely dependent on the US Government and the Global Fund for its response. The States led responses depend on the World Bank credit facility. With ongoing donor withdrawal of funding support, the HIV program in Nigeria may suffer a major setback.

Tanzania recently paved the way for many other African government to follow: it committed substantial resources through the enactment of an act establishing the AIDS Trust Fund and HIV Response Fund.

Equal Health and Rights Access Advocacy Initiative (EHRAAI) and all 13-member organizations of The Nigeria Network of People Who Use Drugs(NNPUD) call on the government of Nigeria through the House Committee on AIDS, Tuberculosis and Malaria of the National Assembly to increase the HIV/AIDS allocation for 2018 budget. The budget should support PLHIV access to ART without the institution of user fees.

Equal Health and Rights Access Advocacy Initiative (EHRAAI) and all 13-member organizations of The Nigeria Network of People Who Use Drugs(NNPUD) are working to support all global, regional and national efforts towards improving new Life Saving Harm Reduction, HIV Prevention/Treatment and Effective Research endeavors.

We will continue to support the government’s efforts towards developing a nationally relevant HIV vaccine. In collaboration with our long-time partner NHVMAS, we will continue to work on public education, updates and awareness raising about new development in the field of HIV vaccine and cure research.

We look forward to the government’s blueprint on the way to ensuring an end to AIDS by 2030.

Why the world should keep the hope for an HIV vaccine

Why the world should keep the hope for an HIV vaccine

By Ethel Makila, Associate Director, Advocacy Policy and Communications at the International AIDS Vaccine Initiative

In commemoration of the 2018 HIV Vaccine Awareness Day (HVAD2018), the International AIDS Vaccine Initiative (IAVI), Africa free of New HIV infections( AfNHi), and Media for Environment, Science, Health and Agriculture (MESHA) with support from AVAC, hosted a science café with scientists, media, community representatives and HIV vaccine advocates.

Discussions of the15 May 2018 forum which took place in Nairobi, Kenya, highlighted the global and regional progress towards HIV vaccine research and development, as well as advocates and community perspectives on the need for an HIV vaccine in Africa.

After close to three decades of research, scientists are still trying to develop a safe, effective and accessible vaccine against HIV. The journey towards finding the vaccine has been full of challenges and necessitated long-term commitments; global collaborations; and millions of dollars in funding.

During the May 15 forum, journalists were eager for answers as to the exact progress of the HIV vaccine development process and why there are still passionate advocates for a seemingly elusive venture.Why the world should keep the hope for an HIV vaccine

In his presentation, IAVI Africa Regional Director Prof Anatoli Kamali highlighted the persistent challenge of new HIV infections despite the great achievements in the fight against HIV and AIDS through treatment and prevention programs.

The rate of new HIV infections over the last 10 years still remains high. In 2016 alone, there were 1.8 million new infections’ said Kamali. ‘Nearly 70 percent of those new infections occurred in sub-Saharan Africa’, he added.

Prof Kamali emphasized that without a vaccine, the world may actually see increases in infection rates. He cited emerging challenges including a resistance to life-saving HIV drugs, and a surge in the growth of the adolescent population in sub Saharan Africa – the population with the highest rate of new HIV infections globally – as a threat to the progress in tackling the HIV epidemic.

As he made a case for the continued investment of time and resources in research to find an HIV vaccine, Prof Kamali reminded the audience that the biggest impacts in the eradication or control of infectious diseases in the history of public health have been achieved through vaccination.

He also referred to recent modeling analyses conducted for low- and middle-income countries which show that even with a 70 percent efficacious and well-adopted vaccine as part of the global HIV/AIDS response, majority of the annual new HIV infections can be prevented.

PATH Advocacy Manager in Kenya, Pauline Irungu added that beyond saving lives, an effective HIV vaccine could potentially improve the social economic out-look for Africa by removing the burden posed by rising costs of treatment and care of HIV infected populations.

‘Since the 1950’s, Global health R&D investment of US$26milion towards polio vaccine has resulted in treatment cost savings worth US$180 billion,’ argued Irungu, adding that overall, research and development is linked to economic prosperityand improved quality of life.

From the community perspective, Inviolata Mmbwavi, the National Coordinator of International Community of Women Living with HIV – Kenya gave a passionate account of why she has dedicated her life to advocate for HIV prevention strategies, particularly awareness creation and vaccine research and development.

‘As a mother, and as a person who got infected at a tender age, the thought of the rising cases of new HIV infections among young people makes my stomach churn’ said Mmbwavi.

‘I look forward to the day we shall have a safe, effective and accessible HIV vaccine for all. Then I can rest assured that we can end HIV and AIDS for good,’ she concluded.

Keep up with NHVMAS activities on our social media platforms and join the conversation

Facebook: www.facebook.com/nhvmas

Twitter: @nhv_mas

FMoH RESPONDS TO OPEN LETTER TO HON MINISTERS FOR HEALTH AND HON MINISTER OF LABOUR & PRODUCTIVITY

Civil Society for HIV/AIDS in Nigeria

Network of People Living with HIV/AIDS in Nigeria

Re: Open letter to the Honourable Minister of Health and Honourable Minister of Labour & Productivity

  Your open letter to the Honourable Ministers’ of Health and Labour on the negative impact the ongoing strike by the Joint Health Workers Union (JOHESU) is having on People Living with HIV/AIDS (PLHIV) who are accessing care and treatment across government facilities nationwide refers.

2. The government acknowledges your concern regarding the negative impact this strike action is having on the health services in the country generally, treatment of people living with HIV/AIDS inclusive, and assures your organizations that it isdoing everything possible to facilitate early resolution of this industrial dispute

3. While we await early resolution of this industrial dispute, please be informed that government is doing her possible best to keep the health facilities open so that people living with HIV and other patients can access healthcare. Information available to us shows that health workers lawfully discharging their duties were assaulted, manhandled and chase away from their duty-posts by officials of this striking union.

4. It is important to remind you that as responsible organizations, you are expected to be part of the facilitation of early resolution of this industrial dispute and not to take sides or blame parties or individuals. The content of your letter was intended to blackmail the HMH and should be withdrawn.

5. You are also aware of the role played by the trustees of Kingdom Human Right Foundation International, who got an injunction from the National Industrial Court of Nigeria. We should all follow up and make JOHESU obey the ruling and suspend the strike by resuming at their duty posts and provide healthcare to Nigerians.

6. Please accept the warm regards of the Honourable Minister of Health.

Thank you

Dr. Sunday A. Aboje

National Coordinator, HIV/AIDS Division, FMOH

For: Honourable Minister of Health.

Imagine a world with HIV vaccine

Imagine a world with HIV vaccine

Imagine a world with HIV vaccine

By Elizabeth Williams Talatu

Now let’s discuss what a vaccine is in a lay man’s terms. I come down with malaria and I rush to the hospital. Once I get to the hospital, I am given malaria drugs which I take and before you know it, malaria is gone; as though it were never there in the first place. Now imagine a vaccine for HIV that would do what the malaria drugs do, impressive right.

Yes, the world will be better, HIV will be wiped off the face of the earth, no more deaths as a result of HIV, the stigma and discrimination will stop, and ultimately we will have a HIV-free generation.

Now that’s the dream.

But then again, the vaccine isn’t here yet with lots of money invested day in day out towards developing one.

Whilst we envisage the reality of our dream, lets practice healthy sexual behaviors by abstaining from sex, using a condom, and been faithful to one mutually faithful partner. Go and know your HIV status today and preach the word, show love to persons living with HIV.

Happy HIV Vaccine Day to us all!

YouthRISE Nigeria joins NHVMAS to celebrate the 2018 HIV Vaccine Awareness Day

YouthRISE Nigeria joins NHVMAS to celebrate the 2018 HIV Vaccine Awareness Day

We can recall, many decades ago, how breakthroughs in vaccine development helped bring many infectious diseases under control. This is yet to be the case with HIV infection though we know that like other infectious diseases, a HIV Vaccine will turn the tide.

According to the World Health Organisation (WHO) over 34 million lives have been lost due to AIDS. Between 1990 and 2014, the number of people living with HIV rose from 8 million to 36.9 million.

In Nigeria, over 3 million people are reported to be living with HIV with several millions of people at risk of getting infected. With vaccines these would have been less worrisome public health concerns.

Today, we acknowledge the relentless determinations of advocates, scientists, and communities who have continued to make bold efforts towards development of HIV vaccines.

We also acknowledge the donor communities who have shown support for this aspiration – support for research and support for advocacy.

YouthRISE Nigeria, an organization working to promote evidence based drug policy, research and programs for vulnerable populations, join voices with global advocates that this is not a time to retreat. This is the time to significantly increase all investments in the effort to develop HIV vaccine.

With a HIV vaccine, we can ensure a HIV free generation.